A case of legionellesis pneumonia verified by isolation of legionella pneumophila serogroup 1 from bronchoalveolar lavage treated with levofloxacine and tigecycline


Cite item

Full Text

Abstract

A male patient received non-chemotherapeutic drugs which induced deep neutropenia complicated with sepsis, bilateral pneumonia, acute respiratory insufficiency. Artificial pulmonary ventilation was applied. The examination of bronchoalveolar lavage showed the presence of the culture L. pneumophila (serogroup 1) in a concentration 2x103 CFU/ml. Antibacterial therapy with levofloxacin in a dose 1000 mg/day was conducted. In a week not only L.pneumophila but also Acinetobacter baumanii was isolated from bronchoalveolar lavage. Tigecyclin was added to levofloxacin treatment. Two air cavities were found in the left lung. The treatment reduced the size of these cavities, infiltrative changes in the lungs and respiratory insufficiency regressed. The patient was discharged from hospital. This case is the first case in Russia of L.pneumophila isolation from bronchoalveolar lavage. The case is also characterized by use of tigecycline for treatment of combined legionella and akinetobacterial infection and cavities in the lungs in legionella pneumonia.

About the authors

Gennadiy Martinovich Galstyan

Email: ggalst@rambler.ru

Mikhail Yur'evich Drokov

Email: mdrokov@gmail.com

Svetlana Aleksandrovna Katrysh

Email: ggalst@rambler.ru

Galina Aleksandrovna Klyasova

Email: klias@blood.ru

Elena Aleksandrovna Gilyazitdinova

Tat'yana Igorevna Karpova

Email: dragovtceva@ya.ru

Boris Ivanovich Marakusha

Email: marakusha@rambler.ru

Igor' Semenovich Tartakovskiy

Email: itartak@list.ru

G M Galstyan

Hematological Research Center, Moscow

Hematological Research Center, Moscow

M Yu Drokov

Hematological Research Center, Moscow

Hematological Research Center, Moscow

S A Katrysh

Hematological Research Center, Moscow

Hematological Research Center, Moscow

G A Klyasova

Hematological Research Center, Moscow

Hematological Research Center, Moscow

E A Gilyazitdinova

Hematological Research Center, Moscow

Hematological Research Center, Moscow

T I Karpova

N.F. Gamalei Research Institute of Epidemiology and Microbiology, Moscow

N.F. Gamalei Research Institute of Epidemiology and Microbiology, Moscow

B I Marakusha

N.F. Gamalei Research Institute of Epidemiology and Microbiology, Moscow

N.F. Gamalei Research Institute of Epidemiology and Microbiology, Moscow

I S Tartakovsky

N.F. Gamalei Research Institute of Epidemiology and Microbiology, Moscow

N.F. Gamalei Research Institute of Epidemiology and Microbiology, Moscow

References

  1. Pedro-Botet M. L., Sabria-Leal M., Haro М. et al. Nosocomial and community-acquired Legionella pneumonia: clinical comparative analysis. Eur. Respir. J. 1995; 8: 1929-1933.
  2. Joseph C. A., Ricketts K. D. European Working Group for Legionella Infections. Legionnaires' disease in Europe 2007- 2008. Euro Surveill. 2010; 15: 19493.
  3. Тартаковский И. С., Синопальников А. И., Демина Ю. В., Груздева О. А. Профилактика легионеллеза как основа нового направления профилактики нозокомиальных инфекций. Клин. и микробиол. и антимикроб. химиотер. 2010; 4: 272-283.
  4. Cunha B. A. Severe Legionella pneumonia: Rapid presumptive clinical diagnosis with Winthrop-University Hospital's weighted point score system (modified). Heart Lung. 2008; 37: 311- 320.
  5. Gupta S. K., Imperiale T. F., Saros G. A. Evaluation of the Winthrop-University Hospital criteria to identify Legionella pneumonia. Chest 2001; 120: 1064-1071.
  6. Mulazimoglu L., Yu V. L. Can legionnaires disease be diagnosed by clinical criteria? Chest 2001; 120;1049-1053.
  7. Чучалин А. Г., Синкопальников А. И., Тартаковский И. С. и др. Практические рекомендации по диагностике и лечению легионеллезной инфекции, вызываемой Legionella pneumophila серогруппы 1. Клин. микробиол. и антимикроб. химиотер. 2009; 11(1): 4-13.
  8. Ворр L. H., Baltch A. L., Ritz W. J. et al. Activities of tigecycline and comparators against Legionella pneumophila and Legionella micdadei extracellularly and in human monocyte-derived macrophages. Diagn. Microbiol. Infect Dis. 2011; 69: 86-93.
  9. Edelstein P. H., Weiss W. J., Edelstein M. A. Activities of Tigecycline (GAR-936) against Legionella pneumophila in vitro and in guinea pigs with L. pneumophila pneumonia. Antimicrob. Agents Chemother. 2003; 47: 533-540.
  10. Valve K., Vaalasti A., Anttila V. J., Vuento R. Disseminated Legionella pneumophila infection in an immunocompromised patient treated with tigecycline. Scand. J. Infect. Dis. 2010; 42: 152-155.
  11. Галстян Г. М., Кесельман С. А., Фоломеев В. Н., Сотников В. Н. Использование устройства, сохраняющего стойкую трахеостому. Инфекции в хир. 2007; 5 (4): 50-54.
  12. Fraser D. W., Tsai T. R., Orenstein W. Legionnaires' disease: description of an epidemic of pneumonia. N. Engl. J. Med. 1977; 297 (22): 1189-1197.
  13. Бобылева З. Д. Легионеллезная пневмония: Диагностика, клиническая картина, лечение, отдаленные результаты (по материалам эпидемической вспышки легионеллеза в Свердловской области): Автореф. дис. ... д-ра мед. наук. М., 2010.
  14. van Staa T. P., Boulton F., Cooper C. et al. Neutropenia and agranulocytosis in England and Wales: Incidence and risk factors. Am. J. Hematol. 2003; 72: 248-254.
  15. Andres E., Kurtz J.-E., Maloisel F. Nonchemotherapy drug-induced agranulocytosis: experience of the Strasbourg teaching hospital (1985-2000) and review of the literature. Clin. Lab. Haematol. 2002; 24: 99-106.
  16. Воробьев А. И., Галстян Г. М. Сепсис у гематологических больных. В кн. Воробьев А. И. (ред.): Рациональная фармакотерапия заболеваний системы крови. М.: Изд-во "Литерра"; 2009: 605-613.
  17. Bartram J., Chartier Y., Lee J. V. et al. Legionella and the prevention of legionellosis. Geneva; WHO; 2007.
  18. Прозоровский С. В., Покровский В. И., Тартаковский И. С. Болезнь легионеров (легионеллез). М.: Медицина; 1984.
  19. Санитарно-эпидемиологические правила. Профилактика легионеллеза. СП 3.1.2.2626-10. М.; 2010.
  20. Тартаковский И. С., Новокшонова И. В., Садретдинова О. В. и др. Частота и уровень контаминации Legionella pneumophila потенциально опасных водных объектов в московском регионе. Журн. микробиол. 2010; № 6: 21-26.
  21. Klech H., Pohl W. Technical recommendations and guidelines for bronchoalveolar lavage. Eur. Respir. J. 1989; 2: 561-585.
  22. Kim K. W., Goo J. M., Lee H. J. et al. Chest computed tomographic findings and clinical features of Legionella pneumonia. J. Comput. Assist. Tomogr. 2007: 31: 950-955.
  23. Yu H., Higa F., Koide M. et al. Lung abscess caused by Legionellal species: Implication of the immune status of hosts. Intern. Med. 2009; 48: 1997-2002.

Copyright (c) 2011 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies